Statistics for Collplant Biotechnologies Ltd (id:6868 CLGN)
Valuation metrics
Market cap
42.10M
Enterprise value
33.32M
Trailing P/E (ttm)
-5.65
Forward P/E
-9.42
PEG ratio
-9.42
Price/Sales (ttm)
61.10
Price/Book (mrq)
1.48
Enterprise Value/Revenue
48.36
Enterprise Value/EBITDA
-1.92
Overview
Shares outstanding
11.45M
Float
7.82M
Shares short
12.07K
% Held by insiders
3.00%
% Held by institutions
3.00%
Average volume (10 days)
13.77K
Average volume (90 days)
Price summary
52-Week low
3.24
52-Week high
6.99
52-Week change
-87.14%
Beta
3.00
50-Day moving average
4.06
200-Day moving average
4.90
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
November 21, 2016
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
81.83%
Operating margin
-1,769.48%
Operational effectiveness
Return on assets
-33.77%
Return on equity
-61.55%
Income statement
Revenue (ttm)
5.00
Revenue per share (ttm)
5.00
Quarterly revenue growth (yoy)
3.00
Gross profit (ttm)
8.97M
EBITDA
-17,308,000.00
Net income to common (ttm)
-17,471,000.00
Diluted EPS (ttm)
-1.53
Quarterly earnings growth (yoy)
-90.70%
Balance sheet
Total cash (mrq)
18.92M
Total cash per share (mrq)
1.65
Total debt (mrq)
3.38M
Total Debt/Equity (mrq)
16.33
Current ratio (mrq)
627.40%
Book value per share (mrq)
2.48
Cash flow
Cash flow statement
-2,750,000.00
Levered free cash flow (LFCF)
2.13M